0812 GMT - RELX's performance update is reassuring, Baader analyst Alexandre Desprez writes in a research note. The reduction in federal funding for research seems to have no visible impact on the group, the analyst notes. The information-and-analytics company reported strong growth in article submissions at its scientific, technical and medical division. This will likely alleviate investors' concerns about the group's research segment, Desprez says. Shares are up 0.5% at 3,963 pence. (najat.kantouar@wsj.com)
(END) Dow Jones Newswires
April 24, 2025 04:12 ET (08:12 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。